Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003)

NCT01353911 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

368

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Grazoprevir
DRUG: Boceprevir
DRUG: Placebo for Grazoprevir
DRUG: Placebo for Boceprevir
DRUG: Peg-interferon alfa-2b
DRUG: Ribavirin

Sponsor

Merck Sharp & Dohme LLC